IRCT201309079429N3已完成未知
Therapeutic effects of Montelukast and Fluticasone in children under 5 years with recurrent wheeze
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 5 years（—）
- 性别
- All
入选标准
- •children under 5 years, with more than 3 times the number of wheezing in clinical studies and no clinical evidence of other predisposing factors. Exclusion criteria: children under 5 years who have evidence of other predisposing factors for wheezing, such as Gastro Esophageal Reflux Disease, Cystic Fibrosis, heart disease, airway disease, congenital anatomical issues.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effects of Montelukast treatment in asthmatic children under 5 yearsAsthma in children.J40?J47AsthmaIRCT201204099429N1Tabriz University of Medical Sciences, Assistance Research68
已完成
3 期
Therapeutic effect of Montelukast in patients with oral lichen planusLichen Planusichen Planus.IRCT2012110811389N2Vice Chancellor for Research , Hamedan University of Medical Sciences200
已完成
3 期
Evaluation of montelukast efficacy on clinical and FEV1/PEFR improvement in acute basthma attackAcute attack asthma.AsthmaIRCT2015092215446N5Vice chanceller for research, Ahvaz Jundishapur University of Medical Sciences80
招募中
2 期
Evaluation of the effect of Montelukast in allergic rhinitis, Evaluation of the effect of neotadine in the treatment of allergic rhinitisIRCT20211205053277N1Tehran University of Medical Sciences60
进行中（未招募）
1 期
Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19)EUCTR2020-001747-21-PTInstituto de Saúde Pública Universidade Porto160